70
Participants
Start Date
September 30, 2000
Primary Completion Date
February 28, 2007
Study Completion Date
February 29, 2008
Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone.
Given intravenously on days 1,11,43: Cyclophosphamide 750mg/m2, doxorubicin 50mg/m2, vincristine 1.4mg/m2. Given orally on days 1-5,22-27: Pednisolone 50mg/m2
Radiotherapy
Total 45 Gy in 25 fractions
Auckland Hospital, Auckland
Liverpool Hospital, Liverpool
Royal Prince Alfred Hospital, Camperdown
Westmead Hospital, Wentworthville
Calvary Mater Newcastle, Newcastle
Peter MacCallum Cancer Centre, East Melbourne
Waikato Hospital, Hamilton
Andrew Love Cancer Care Centre, Geelong Hospital, Geelong
The Wesley Radiation Oncology Pty Ltd, Auchenflower
Royal Brisbane Hospital, Herston
Mater QRI, South Brisbane
Princess Alexandra Hospital, Woolloongabba
East Coast Cancer Centre, John Flynn Hospital, Tugun
North Queensland Oncology Service, Townsville
Royal Adelaide Hospital, Adelaide
Sir Charles Gairdner Hospital, Nedlands
Royal Hobart Hospital, Hobart
Launceston General Hospital, Launceston
Wollongong Hospital, Wollongong
Palmerston North Hospital, Palmerston North
Australasian Leukaemia and Lymphoma Group
OTHER
Australasian Radiation Oncology Lymphoma Group
OTHER
Wesley Research Institute
OTHER
Trans Tasman Radiation Oncology Group
OTHER